Aegis will launch coVID-19 antibody control using a platform to verify a dry blood stain pattern on August 31 and is able to settle for patterns and perform up to 10,000 day-consistent controls with a 24-hour delay. The unique ability to verify a dry blood pattern will be consistent with allowing verification to take place without the need for an invasive blood test required lately by other labs. “Our control combines the quality of aegis and the excellence of laboratory testing with the convenience of taking dry samples. blood patterns. By allowing patients to avoid a painful and irregular blood test, we improve access to control and supply physicians and patients with a fast, high-quality, affordable and hassle-free option. Our committed team of lab scientists worked diligently to leverage Aegis’ extensive roles in dry blood stain generation and temporarily proposed this valuable diagnostic tool to help combat COVID-19,” said Dr. Frank Basile, CEO of Aegis Sciences Corporation.
Aegis Sciences Corporation has validated and introduced a qualitative antibody check capable of detecting IgG antibodies in 24 hours. The laboratory will use a forged phase fluoroimmunometric control with 99.9% expressiveness and a sensitivity of 96.1%. Samples deserve to be taken using a finger tap method to allow a dry blood staining pattern to be taken. Tests are conducted in a highly automated manner to ensure certain accuracy, accuracy and reproducibility. “The Aegis COVID-19 antibody screening test has been developed and validated in accordance with the needs of the FDA Emergency Use Authorization (USA) and will provide an incredibly delicate and express result in a timely manner to enable the Ministry of Health (DOH), doctors and patients to make the most productive decisions”. Dr. Matthew Hardison, executive vice president of laboratory operations, said.
“We believe this is an essential detail to understand the extent to which the American population developed an immune reaction to the virus after exposure.This can be a marker in the history of infection and contribute to efforts to mitigate a imaginable problem by resurgence of falls,” said Dr. Frank Basile, CEO of Aegis Sciences Corporation.
Aegis also performs COVID-19 viral tests and has the ability to perform 30,000 day-consistent tests and more than 750,000 month-consistent tests within 24 to 48 hours.
For more facts and highlights on how to perform Aegis’ COVID-19 verification service, visit www.aegislabs.com, email [email protected], or call 615-99COVID (615.992.6843).
Aegis Sciences Corporation Founded in 1990, Aegis Sciences Corporation is a nashville, Tennessee-based lab science company that provides science-based testing and consulting to clients such as healthcare providers, pharmaceutical corporations, professional and amateur sports organizations, leading college universities, and college sports programs. Organize Fortune 500 corporations and government agencies in the United States. For more information, visit https://www.aegislabs.com/.
Contact: Minh Phone Number: 615-610-0310 Email: [email protected]